Mixed bag
The facility was designed by a “mixed-bag” of industry, from small and large biopharma firms to vendors who reported back that “the facility should be a good blend between stainless steel and single-use systems,” O’Driscoll said.
It was also constructed to have the capacity to be a multi-purpose, multi-product facility, with capacity to look after both mammalian and microbial and have a very strong focus on bioanalytics and on product and process characterisation.
Furthermore, industry is highly represented at NIBRT with Alexion, Regeneron, Biomarin, Eli Lilly, Amgen, and MSD all represented.